Farxiga Approval Expands Use to More Patients With Heart Failure
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
Clinicians should have a high index of suspicion for ARVC in patients with unexplained sudden cardiac arrest, syncope, or arrhythmia and a strong family history of similar events.
A 31-year-old woman with no significant medical history presents with intermittent heart palpitations, dizziness, shortness of breath, and fatigue provoked by exercise. Can you make the diagnosis?
Investigators conducted a study to evaluate the relationship between coffee intake and incident arrhythmia, cardiovascular disease, and mortality.
The patient experienced random short bursts of chest pain and felt that she was going to pass out, starting 2 weeks before ED visit.
Researchers determined the effects of early rhythm control therapy in patients diagnosed with atrial fibrillation with signs and symptoms of heart failure.
Experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, discuss the connections between obstructive sleep apnea and sudden cardiac death.
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
High-strength magnets may cause implants to switch to ‘magnet mode,’ stopping normal functioning until the magnet is moved away from the device
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.